Keywords: کارسینوم مجرای تهاجمی; APC; antigen presenting cell; APOBEC; apolipoprotein B mRNA editing enzyme catalytic polypeptide-like; BRCA1/2; breast cancer 1/2; BCSS; breast cancer specific survival; B2M; β-2-microglobulin; CAF; cancer associated fibroblast; CCL; chemokine ligand; CD
مقالات ISI کارسینوم مجرای تهاجمی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارسینوم مجرای تهاجمی; Breast; Breast neoplasms; Triple negative breast neoplasms; Metaplastic breast cancer; Medullary breast cancer; Adenoid cystic breast cancer; Apocrine breast cancer; Invasive ductal carcinoma; Invasive lobular carcinoma; Prognosis;
Keywords: کارسینوم مجرای تهاجمی; microRNA-331; Breast cancer; Breast benign tumors; Ductal adenocarcinoma; Lobular adenocarcinoma; Biomarker; ASCO; American Society of Clinical Oncologists; AUC; Area under the curve; CAP; College of American Pathologists; cDNA; Complementary DNA; DCIS; D
Keywords: کارسینوم مجرای تهاجمی; Breast; Tumoral pseudoangiomatous stromal hyperplasia (PASH); Ultrasound; Excision; Histopathology; PASH; pseudoangiomatous stromal hyperplasia; USG; ultrasonography; U-BI-RADS; ultrasound-breast imaging-reporting and data system (American College of Radi
Keywords: کارسینوم مجرای تهاجمی; IDC; invasive ductal carcinoma; IL-35; interleukin-35; Tregs; regulatory T cells; TILs; tumor-infiltrating lymphocytes; EBI3; Epstein-Barr Virus (EBV)-induced gene 3; Bregs; regulatory B cells; PFS; progression-free survival; OS; overall survival; ER; est
Keywords: کارسینوم مجرای تهاجمی; Carcinoma, intraductal, noninfiltrating; carcinoma, ductal, breast; mammography; breast carcinoma in situ; breast neoplasms; DCIS; ductal carcinoma in situ; ER; estrogen receptor; IDC; invasive ductal carcinoma; PR; progesterone receptor;
Keywords: کارسینوم مجرای تهاجمی; Modified lymph node ratio; Breast cancer; Prognosis; Nomogram; LN; lymph nodes; LNR; lymph node ratio; mLNR; modified lymph node ratio; pN; pathologic positive lymph node; C-index; Concordance index; ALND; axillary lymph node dissection; IDC; invasive duc
Keywords: کارسینوم مجرای تهاجمی; Breast cancer; Leptin; Leptin receptor; Subcellular localization; Immunohistochemistry; Immunocytochemistry; AT; adipose tissue; CBT; cancer breast tissue; IDC; invasive ductal carcinoma; ICC; immunocytochemistry; IHC; immunohistochemistry; LEP; leptin; L
Keywords: کارسینوم مجرای تهاجمی; Breast; myoepithelial carcinoma; invasive ductal carcinoma; cytogenetic analysis; chromosomal rearrangement;
Keywords: کارسینوم مجرای تهاجمی; TomosÃntesis; MamografÃa 2D; Distorsión arquitectural; Cáncer ductal infiltrante; Cicatriz radiada; Tomosynthesis; Digital mammography; Architectural distortion; Invasive ductal carcinoma; Radial scar;
Keywords: کارسینوم مجرای تهاجمی; Invasive ductal carcinoma with predominant intraductal component; Invasive ductal carcinoma; HER2 overexpression; Disease-free survival;
Keywords: کارسینوم مجرای تهاجمی; Invasive ductal carcinoma; Young women; HER2 over expression; Disease-free survival; Molecular phenotype;
Keywords: کارسینوم مجرای تهاجمی; Breast; Mucinous carcinoma; Invasive ductal carcinoma; Mucin; Mucin index; Computer-aided methodology
Keywords: کارسینوم مجرای تهاجمی; Screening mammography; resident education; simulation; breast imaging; ACR; American College of Radiology; ALH; atypical lobular hyperplasia; BCSC; Breast Cancer Surveillance Consortium; BI-RADS; Breast Imaging Reporting and Data System; CAD; computer-aid
Keywords: کارسینوم مجرای تهاجمی; Ductal carcinoma in situ; Invasive ductal carcinoma; Biomarkers; Gene expression; Myoepithelial cells; Tumor microenvironment
Keywords: کارسینوم مجرای تهاجمی; Morphometry; Invasive ductal carcinoma; Microvessel; Grade;
Keywords: کارسینوم مجرای تهاجمی; Pleomorphic lobular carcinoma-in-situ; DCIS; Invasive ductal carcinoma; Invasive lobular carcinoma; Breast cancer;
Keywords: کارسینوم مجرای تهاجمی; Breast cancer surgery; Margins; Breast conserving therapy; Mastectomy; Residual disease; Local recurrence; mm; millimeters; BCT; breast conserving therapy; 5-yr LR; five year local recurrence; cm; centimeter; vs.; versus; IDC; invasive ductal carcinoma; D
Keywords: کارسینوم مجرای تهاجمی; MRI; magnetic resonance image; ER; estrogen-receptor; PR; progesterone-receptor; AC; doxorubicin and cyclophophamide; SATs; secondary appendiceal tumors; GI; gastrointestinal; ILC; invasive lobular carcinoma; IDC; invasive ductal carcinoma; Breast cancer;
Keywords: کارسینوم مجرای تهاجمی; Estrogen receptor β; Invasive ductal carcinoma; Lobular cancer; Tumor infiltrating; leukocytes; ERβ-selective agonist
Keywords: کارسینوم مجرای تهاجمی; Invasive ductal carcinoma; Diffusion-weighted MRI; Lymph nodes; Metastasis
Keywords: کارسینوم مجرای تهاجمی; Breast Conserving Surgery; Invasive lobular carcinoma; Invasive ductal carcinoma; Surgical oncology; Re-excision of margins; BCT; Breast Conserving Therapy; BCS; Breast Conserving Surgery; IBC; Invasive Breast Cancer; ILC; Invasive Lobular Carcinoma; IDC;
Keywords: کارسینوم مجرای تهاجمی; Breast cancer; Tumor microenvironment; Extracellular matrix; Tumor stroma component; ECM-related signatures; ER; estrogen receptor; IDC; invasive ductal carcinoma; DCIS; ductal carcinoma in situ; FEC; 5-fluorouracil+doxorubicin+cyclophosphamide; NKI; Neth
Keywords: کارسینوم مجرای تهاجمی; Breast cancer; Iran; Cancer registry; Invasive ductal carcinoma;
Keywords: کارسینوم مجرای تهاجمی; IDC; invasive ductal carcinoma; DCIS; ductal carcinoma in situ; TDLU; terminal ductal lobular unit; Breast; Estrogens; Androgens; Tissue; Cancerous; Benign;
Keywords: کارسینوم مجرای تهاجمی; breast carcinoma; invasive ductal carcinoma; renal cell carcinoma; tumor-to-tumor metastasis
Keywords: کارسینوم مجرای تهاجمی; Invasive ductal carcinoma; Breast cancer; Ductal carcinoma in situ; Breast conserving surgery; Margin status; Margin; Margin clearance; Perioperative tools
Keywords: کارسینوم مجرای تهاجمی; lncRNA; long/large noncoding RNA; Xist; X-inactive specific transcript; mESC; mouse embryonic stem cell; Evf2; embryonic ventral forebrain 2; Six3os; sine oculis-related homeobox 3 homolog, opposite strand; Dlx1as; distal-less homeobox 1, antisense; EGO;
PD-L1 in breast cancer: comparative analysis of 3 different antibodies
Keywords: کارسینوم مجرای تهاجمی; Breast cancer; Invasive ductal carcinoma; Programmed cell death ligand-1; Immunohistochemistry; Comparative analysis; Three antibodies;
Development of a New Monochrome Multiplex qPCR Method for Relative Telomere Length Measurement in Cancer
Keywords: کارسینوم مجرای تهاجمی; scg; single-copy genes; mcs; multiple-copy sequences; T; telomere quantity; S; scg quantity; M; mcs quantity; DNA; deoxyribonucleic acid; PCR; polymerase chain reaction; MMQPCR; monochrome multiplex quantitative PCR; EDTA; ethylenediaminetetraacetic acid;
MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer
Keywords: کارسینوم مجرای تهاجمی; Breast cancer; miRNA; miRNA cluster; miRNA co-expression; Microarray; BC; breast cancer; DCIS; ductal carcinoma in-situ; ECM; extracellular matrix; EMT; epithelial to mesenchymal transition; ER; estrogen receptor; GSEA; gene set enrichment analysis; IDC;
High snail expression predicts a poor prognosis in breast invasive ductal carcinoma patients with HER2/EGFR-positive subtypes
Keywords: کارسینوم مجرای تهاجمی; Breast cancer; Invasive ductal carcinoma; Molecular subtype; HER-2-Positive; EGFR-Positive; Prognosis;
Loss of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation
Keywords: کارسینوم مجرای تهاجمی; Breast Cancer; c-KIT; Epigenetics; DNA methylation; Immunohistochemistry; ADH; Atypical ductal hyperplasia; BCA; Bicinchoninic acid; CML; Chronic myelogenous leukemia; CK5/6; Cytokeratin 5/6; CK903; Cytokeratin 903; DCIS; Ductal Carcinoma in situ; ER; Est
ADC at 3.0â¯T as a noninvasive biomarker for preoperative prediction of Ki67 expression in invasive ductal carcinoma of breast
Keywords: کارسینوم مجرای تهاجمی; Invasive ductal carcinoma; Diffusion weighted imaging; Ki67; Magnetic resonance imaging;
Pre-treatment functional MRI of breast cancer: T2* evaluation at 3â¯T and relationship to dynamic contrast-enhanced and diffusion-weighted imaging
Keywords: کارسینوم مجرای تهاجمی; ADC; Apparent Diffusion Coefficient; BIC; Bayesian Information Criterion; BOLD; Blood Oxygen Level Dependent; CA; Custer Analysis; DCE-MRI; Dynamic Contrast-Enhanced - MRI; DWI; Diffusion-Weighted Imaging; FOV; Field Of View; GRE; GRadient Echo; HR FS GRE
The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential
Keywords: کارسینوم مجرای تهاجمی; APC/C; anaphase-promoting complex/cyclosome; ASF1; antisilencing function 1; BRAF35; BRCA2-associated factor 35; BRCA2; breast cancer 2 protein; CAF-1; chromatin assembly factor 1; CR; cysteine rich; DCIS; ductal carcinoma in situ; DNMT3B; DNA methyltrans
Achieving clear margins. Directed shaving using MarginProbe, as compared to a full cavity shave approach
Keywords: کارسینوم مجرای تهاجمی; BCS; breast conserving surgery; IDC; invasive ductal carcinoma; DCIS; ductal carcinoma in situ; ER; estrogen receptor; PR; progesteron receptor; HER2; human epidermal growth factor receptor 2;
The First Case of HER2+ Invasive Ductal Carcinoma Arising From a Breast Hamartoma and Literature Review
Keywords: کارسینوم مجرای تهاجمی; Breast cancer; Her2; Hamartoma; DCIS; ductal carcinoma in situ; LCIS; Lobular carcinoma in situ; IDC; invasive ductal carcinoma; ILC; invasive lobular carcinoma;
Research papersThe breast lesion excision system (BLES) under stereotactic guidance cannot be used as a therapeutic tool in the excision of small areas of microcalcifications in the breast
Keywords: کارسینوم مجرای تهاجمی; ADH; atypical ductal hyperplasia; BLES; breast lesion excision system; CNB; core needle biopsy; DCIS; ductal carcinoma in situ; IDC; invasive ductal carcinoma; LCIS; lobular carcinoma in situ; RF; radiofrequency; US; ultrasound; VABB; vacuum-assisted brea
Improving digital breast tomosynthesis reading time: A pilot multi-reader, multi-case study using concurrent Computer-Aided Detection (CAD)
Keywords: کارسینوم مجرای تهاجمی; ACR; American College of Radiology; ANOVA; Analysis of variance; AUC; Area Under the ROC Curve; BI-RADS®; Breast Imaging Reporting and Data System; CAD; computer-aided detection; CC; craniocaudal; CI; confidence interval; CRF; case report form; CTC; CT c
Role of miR-139 as a surrogate marker for tumor aggression in breast cancer
Keywords: کارسینوم مجرای تهاجمی; Breast cancer; Invasive ductal carcinoma; Micro RNA; MicroRNA-139; Oncogenesis; Tumor progression;
Annexin A1 influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes
Keywords: کارسینوم مجرای تهاجمی; ALH; atypical lobular hyperplasia; BC; breast cancer; BEC; blood endothelial cell; BL; basal-like; CAF; cancer-associated fibroblast; DC; dendritic cells; DCIS; ductal carcinoma in situ; EAE; experimental autoimmune encephalomyelitis; EMT; epithelial-mese
Replacing single-view mediolateral oblique (MLO) digital mammography (DM) with synthesized mammography (SM) with digital breast tomosynthesis (DBT) images: Comparison of the diagnostic performance and radiation dose with two-view DM with or without MLO-DB
Keywords: کارسینوم مجرای تهاجمی; AGD; average glandular dose; BCS; breast conserving surgery; BI-RADS; breast imaging reporting and data system; CC; cranio-caudal; DBT; digital breast tomosynthesis; DCIS; ductal carcinoma in situ; DM; digital mammography; FDA; food and drug administratio
Loss of FAT1 during the progression from DCIS to IDC and predict poor clinical outcome in breast cancer
Keywords: کارسینوم مجرای تهاجمی; Breast cancer; Ductal carcinoma in situ; Invasive ductal carcinoma; FAT1; β-catenin
Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer
Keywords: کارسینوم مجرای تهاجمی; Invasive ductal carcinoma; Invasive lobular carcinoma; Isolated tumor cells; SLN biopsy; Stage migration;
Collagen fibers mediate MRI-detected water diffusion and anisotropy in breast cancers
Keywords: کارسینوم مجرای تهاجمی; 2D; two-dimensional; 3D; three-dimensional; aDW; average diffusion weighted; ADC; apparent diffusion coefficient; Col1; collagen 1; DTI; diffusion tensor imaging; ECM; extracellular matrix; ER; estrogen receptor; FA; fractional anisotropy; FOV; field of v
A laser microdissection-based workflow for FFPE tissue microproteomics: Important considerations for small sample processing
Keywords: کارسینوم مجرای تهاجمی; FFPE; formalin-fixed paraffin-embedded; AR; antigen retrieval; SDS; sodium dodecyl sulfate; MALDI MSI; matrix-assisted laser desorption/ionization mass spectrometry imaging; CA; citric acid; CAAR; citric acid antigen retrieval; TNBC; triple negative breas
Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells
Keywords: کارسینوم مجرای تهاجمی; 2AB; 2-aminobenzamide; ALCAM; Activated leukocyte cell adhesion molecule; ALCAMe; Endogenous ALCAM from MDA-MB-231 cells; ALCAMgly; Recombinant glycosylated ALCAM expressed in HEK-293 cells; ALCAMnongly; Non-glycosylated ALCAM; ADAM17; A disintegrin and m
STAT3-induced WDR1 overexpression promotes breast cancer cell migration
Keywords: کارسینوم مجرای تهاجمی; WDR1; WD repeat domain 1; STAT3; signal transducer and activator of transcription 3; BCC; breast cancer cell; ChIP; chromatin immunoprecipitation; DCIS; ductal carcinoma in situ; FFPE; formalin-fixed, paraffin-embedded; F-actin; filamentous actin; FBS; fe
X chromosome gain in male breast cancer
Keywords: کارسینوم مجرای تهاجمی; Male breast cancer; Invasive ductal carcinoma; X chromosome; Genetic marker; FISH